KRKarabo Ramatapa

Karabo Ramatapa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karabo Ramatapa has a total of 3 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Recent Advances in Aloe vera as a Therapeutic Strategy Against Drug-Resistant Pseudomonas aeruginosa: Phytochemistry, Mechanisms, and Translational Perspectives

    by Karabo Ramatapa, Ivy Rukasha, Saheed Sabiu, Mduduzi Mokoena

    Pseudomonas aeruginosa is a major opportunistic pathogen associated with nosocomial infections, antimicrobial resistance, and persistent biofilm formation, highlighting the need for alternative therapeutic strategies. This review critically evaluates the current evidence on the phytochemistry, antimicrobial, antibiofilm, anti-inflammatory, and wound-healing properties of Aloe vera (Aloe barbadensis Mill.) against P. aeruginosa. Relevant peer-reviewed literature from major scientific databases was examined to summarize the phytochemical constituents of A. vera, their proposed mechanisms of action, therapeutic applications, safety considerations, and emerging approaches, including nanotechnology and computational drug discovery. The available evidence indicates that anthraquinones, polysaccharides, flavonoids, and related phytochemicals contribute to antibacterial activity, inhibition of biofilm formation, modulation of host inflammatory responses, and promotion of wound healing. However, considerable variability in phytochemical composition, limited pharmacokinetic and toxicological data, lack of standardized formulations, and insufficient high-quality preclinical and clinical studies continue to hinder clinical translation. Overall, A. vera represents a promising source of adjunctive antimicrobial and anti-virulence compounds for the management of biofilm-associated P. aeruginosa infections. Future research should prioritize phytochemical standardization, mechanistic validation, pharmacokinetic evaluation, and well-designed animal and clinical studies to support the development of safe and clinically effective A. vera-based therapeutics.

  • Open Access

    Computational and Experimental Validation of Aloe Vera Against Pseudomonas Aeruginosa PsrA in Interventive Antibacterial Therapeutics

    by Karabo Ramatapa, Mduduzi Mokoena, Ivy Rukasha, Sabiu Saheed

    Background: Pseudomonas aeruginosa, a multidrug-resistant pathogen, employs biofilm formation as a key virulence strategy, complicating treatment